NL7302521A - Foaming, effervescent capsules - contg. therapeutic agents for rectal and vaginal use - Google Patents
Foaming, effervescent capsules - contg. therapeutic agents for rectal and vaginal useInfo
- Publication number
- NL7302521A NL7302521A NL7302521A NL7302521A NL7302521A NL 7302521 A NL7302521 A NL 7302521A NL 7302521 A NL7302521 A NL 7302521A NL 7302521 A NL7302521 A NL 7302521A NL 7302521 A NL7302521 A NL 7302521A
- Authority
- NL
- Netherlands
- Prior art keywords
- capsules
- foaming
- contg
- rectal
- therapeutic agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
Abstract
The capsules are pref. H2O-sol. and prepd. from gelatine opt. with polyethylene oxides and/or high mol.wt. carbohydrates, are partially filled with (a) a therapeutic agent, (b) an effervescent mixt i.e. a carbonate or bicarbonate and an acid, and (c) a foaming agent, pref. a non-ionogenic surfactant. Prior to insertion, water is introduced into the capsules, to initiate the reaction and so that the mucous membranes do not suffer the imitation which the use of a dry compsn. would cause by dehydration.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL7302521A NL7302521A (en) | 1973-02-23 | 1973-02-23 | Foaming, effervescent capsules - contg. therapeutic agents for rectal and vaginal use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL7302521A NL7302521A (en) | 1973-02-23 | 1973-02-23 | Foaming, effervescent capsules - contg. therapeutic agents for rectal and vaginal use |
Publications (1)
Publication Number | Publication Date |
---|---|
NL7302521A true NL7302521A (en) | 1974-08-27 |
Family
ID=19818292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL7302521A NL7302521A (en) | 1973-02-23 | 1973-02-23 | Foaming, effervescent capsules - contg. therapeutic agents for rectal and vaginal use |
Country Status (1)
Country | Link |
---|---|
NL (1) | NL7302521A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0013056A2 (en) * | 1978-12-22 | 1980-07-09 | Lücker, Peter Wolfgang, Prof. Dr. | Vaginal contraceptive |
EP0088394A2 (en) * | 1982-03-05 | 1983-09-14 | Eisai Co., Ltd. | Stable, effervescent vaginal suppository composition and suppositories made therefrom |
EP0250083A2 (en) * | 1986-06-19 | 1987-12-23 | Alza Corporation | Dosage form with means for governing rate of gas formation |
EP1318790A1 (en) * | 2000-09-19 | 2003-06-18 | Cima Labs Inc. | Pharmaceutical compositions for rectal and vaginal administration |
US7862832B2 (en) | 2003-12-31 | 2011-01-04 | Cima Labs, Inc. | Generally linear effervescent oral fentanyl dosage form and methods of administering |
US8119158B2 (en) | 2003-12-31 | 2012-02-21 | Cephalon, Inc. | Effervescent oral fentanyl dosage form and methods of administering fentanyl |
US8298577B2 (en) | 2003-12-31 | 2012-10-30 | Cephalon, Inc. | Effervescent oral opiate dosage forms and methods of administering opiates |
US8728441B2 (en) | 1998-03-27 | 2014-05-20 | Cephalon, Inc. | Sublingual buccal effervescent |
US8802130B2 (en) | 1998-03-27 | 2014-08-12 | Cephalon, Inc. | Sublingual buccal effervescent |
-
1973
- 1973-02-23 NL NL7302521A patent/NL7302521A/en unknown
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0013056A2 (en) * | 1978-12-22 | 1980-07-09 | Lücker, Peter Wolfgang, Prof. Dr. | Vaginal contraceptive |
EP0013056A3 (en) * | 1978-12-22 | 1980-09-17 | Peter Wolfgang Prof. Dr. Lucker | Vaginal contraceptive |
EP0088394A2 (en) * | 1982-03-05 | 1983-09-14 | Eisai Co., Ltd. | Stable, effervescent vaginal suppository composition and suppositories made therefrom |
EP0088394A3 (en) * | 1982-03-05 | 1983-10-12 | Eisai Co., Ltd. | Stable, effervescent vaginal suppository composition and suppositories made therefrom |
EP0250083A2 (en) * | 1986-06-19 | 1987-12-23 | Alza Corporation | Dosage form with means for governing rate of gas formation |
EP0250083A3 (en) * | 1986-06-19 | 1988-06-01 | Alza Corporation | Dosage form with means for governing rate of gas formation |
US8728441B2 (en) | 1998-03-27 | 2014-05-20 | Cephalon, Inc. | Sublingual buccal effervescent |
US8753611B2 (en) | 1998-03-27 | 2014-06-17 | Cephalon, Inc. | Sublingual buccal effervescent |
US8765100B2 (en) | 1998-03-27 | 2014-07-01 | Cephalon, Inc. | Transmucosal effervescent |
US8802130B2 (en) | 1998-03-27 | 2014-08-12 | Cephalon, Inc. | Sublingual buccal effervescent |
EP1318790A4 (en) * | 2000-09-19 | 2006-02-01 | Cima Labs Inc | Pharmaceutical compositions for rectal and vaginal administration |
EP1318790A1 (en) * | 2000-09-19 | 2003-06-18 | Cima Labs Inc. | Pharmaceutical compositions for rectal and vaginal administration |
US7862832B2 (en) | 2003-12-31 | 2011-01-04 | Cima Labs, Inc. | Generally linear effervescent oral fentanyl dosage form and methods of administering |
US8092832B2 (en) | 2003-12-31 | 2012-01-10 | Cephalon, Inc. | Generally linear effervescent oral fentanyl dosage form and methods of administering |
US8119158B2 (en) | 2003-12-31 | 2012-02-21 | Cephalon, Inc. | Effervescent oral fentanyl dosage form and methods of administering fentanyl |
US8298577B2 (en) | 2003-12-31 | 2012-10-30 | Cephalon, Inc. | Effervescent oral opiate dosage forms and methods of administering opiates |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5271000A (en) | Production of hydrogen peroxide | |
NL7302521A (en) | Foaming, effervescent capsules - contg. therapeutic agents for rectal and vaginal use | |
SE8006889L (en) | WAY TO DELAY GELS OF SLURSES CONTAINING BICARBONATE, CARBONATE AND SILICATE | |
JPS5338690A (en) | Isolation of co-enzyme q | |
DE3262622D1 (en) | Preparation of a glutaraldehyde precursor | |
FR2132521A1 (en) | Effervescent tablets prdn - by controlled drying in effervescent granule formation | |
ES420775A1 (en) | Process for purification of aqueous sodium citrate solutions | |
IT1057859B (en) | Triamcinolone derivs - as antiinflammatory agents | |
GB903959A (en) | Improvements relating to the treatment of granular soils | |
JPS5278781A (en) | Agent for treating solution of acid or alkali | |
JPS521089A (en) | Apparatus for enzymic reaction | |
FR2154323A1 (en) | Effervescent tablets prdn - by controlled drying in effervescent granule formation | |
NL6812254A (en) | Deodorising tablets releasing a chlorine contg gas | |
JPS5346916A (en) | Preparation of hydroxyacetic acid | |
JPS5272393A (en) | Production of neutralized aceive carbon granuls by the activation with steam | |
JPS5427562A (en) | Stabilization of aqueous urocanic acid solution | |
JPS5288294A (en) | Recovery of gypsum from exhaust gas containing sulfur dioxide | |
JPS5278782A (en) | Agent for treating alkali solution | |
GB553004A (en) | Process and apparatus for regenerating exhaled air | |
FR2054067A5 (en) | Glycerol production from allyl alcohol - and percarboxylic acids | |
FR2271207A1 (en) | Methionine prepn. - from 3-methylthiopropyl isonitrile and dialkyl carbonates inpresence of sodium hydride and acid hydrolysis of the product | |
ES336909A1 (en) | Process for the removal of hydrogen sulphide from carbon dioxide and gas mixtures containing carbon dioxide | |
JPS565138A (en) | Water absorbing agent | |
FR2166258A1 (en) | Calcium pangamate - for treatment of cardiovascular disorders | |
FR2275449A1 (en) | Methionine prepn. by three-stage process - from allyl isonitrile via an alkyl isocyanobutenoate |